Dennis T. Ko, M.D. However, a significant proportion of STEMI patients will "fail" to reperfuse following fibrinolytic therapy; indeed, normal coronary blood flow (TIMI flow grade 3) is achieved in ...
The field of fibrinolytic enzymes and antithrombotic therapies has experienced rapid advances in recent years, with a growing focus on harnessing naturally occurring proteases for the targeted ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback